Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederendpoints.news
Endpoints News
Get the latest updates from Endpoints News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated 3 months ago
Commons Clinic raises $26M Series B to offer preventive testing
3 months ago
Commons Clinic, a Los Angeles-based clinic chain focused on musculoskeletal care, has...
BioNTech to acquire CureVac in all-stock deal valued at $1.25B
3 months ago
BioNTech plans to buy mRNA-based cancer immunotherapy and infectious disease vaccine company...
#EHA25: Schrödinger reports early Phase 1 data for MALT1 inhibitor
3 months ago
Schrödinger said its experimental MALT1 inhibitor showed early signs of safety and...
RFK Jr. names eight new ACIP members
3 months ago
Two days after firing all 17 members of the CDC’s vaccine advisory...
Trump officials seek price details as they assess most favored nation plan
3 months ago
Officials in President Donald Trump's administration have spent the month since his...
HHS urges against reviving Chamber of Commerce’s IRA suit
3 months ago
The Trump administration is defending another Biden-era court win in a case...
Federal officials plan listening sessions to address drug competition
3 months ago
The Federal Trade Commission and Department of Justice plan to have three...
Organoid startup raises $21M to test drugs and vaccines in human lymph nodes-in-a-dish
3 months ago
Parallel Bio, a startup that figured out how to grow miniature human...
House appropriators call for FDA tweaks on accelerated approvals, biosimilars
3 months ago
House appropriators are calling on the FDA to boost biosimilar access and...
Nuvation Bio scores first FDA approval for new lung cancer drug
3 months ago
Nuvation Bio on Wednesday won FDA approval with its first commercialized drug...
Endpoints Livestream: What happens when AI thinks in ways we can’t understand?
3 months ago
We’re back for the second time this week! Tomorrow on Post-Hoc Live...
Cabaletta Bio shares CAR-T results in three autoimmune conditions
3 months ago
Cabaletta Bio reported that its CAR-T therapy led to clinical improvements and...